Development and validation of a prognostic model based on immune variables to early predict severe cases of SARS-CoV-2 Omicron variant infection

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant has prevailed globally since November 2021. The extremely high transmissibility and occult manifestations were notable, but the severity and mortality associated with the Omicron variant and subvariants cann...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Tianyu, Man, Qiuhong, Yu, Xueying, Xia, Shuai, Lu, Lu, Jiang, Shibo, Xiong, Lize
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014461/
https://www.ncbi.nlm.nih.gov/pubmed/36936976
http://dx.doi.org/10.3389/fimmu.2023.1157892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014461/
https://www.ncbi.nlm.nih.gov/pubmed/36936976
http://dx.doi.org/10.3389/fimmu.2023.1157892

Ejemplares similares